Radiofrequency ablation of hepatocellular carcinoma: pros and cons.

Among locoregional treatments for hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) has been accepted as the most popular alternative to curative transplantation or resection, and it shows an excellent local tumor control rate and acceptable morbidity. The benefits of RFA have been universally validated by the practice guidelines of international societies of hepatology. The main advantages of RFA include 1) it is minimally invasive with acceptable morbidity, 2) it enables excellent local tumor control, 3) it has promising long-term survival, and 4) it is a multimodal approach. Based on these pros, RFA will play an important role in managing the patient with early HCC (smaller than 3 cm with fewer than four tumors). The main limitations of current RFA technology in hepatic ablation include 1) limitation of ablation volume, 2) technically infeasible in some tumors due to conspicuity and dangerous location, and 3) the heat-sink effect. Many technical approaches have been introduced to overcome those limitations, including a novel guiding modality, use of artificial fluid or air, and combined treatment strategies. RFA will continue to play a role as a representative ablative modality in the management of HCC, even in the era of targeted agents.

[1]  S Nahum Goldberg,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria. , 2005, Radiology.

[2]  Kenneth Hess,et al.  Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases , 2004, Annals of surgery.

[3]  Yi-Cheng Chen,et al.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. , 2004, Gastroenterology.

[4]  Xiao-yan Xie,et al.  [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial]. , 2006, Zhonghua yi xue za zhi.

[5]  Carlo Bartolozzi,et al.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. , 2003, Radiology.

[6]  Dongil Choi,et al.  Comparing the Outcomes of Radiofrequency Ablation and Surgery in Patients With a Single Small Hepatocellular Carcinoma and Well-Preserved Hepatic Function , 2005, Journal of clinical gastroenterology.

[7]  H. Rhim.  Complications of radiofrequency ablation in hepatocellular carcinoma , 2005, Abdominal Imaging.

[8]  Clarisse Dromain,et al.  Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion. , 2008, Radiology.

[9]  H. Rhim,et al.  Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies , 2009, Hepatology.

[10]  J. Bruix,et al.  Novel advancements in the management of hepatocellular carcinoma in 2008. , 2008, Journal of hepatology.

[11]  Eva Pagano,et al.  Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial , 2008, Scandinavian journal of gastroenterology.

[12]  S Nahum Goldberg,et al.  Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[13]  Luigi Solbiati,et al.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. , 2003, Radiology.

[14]  D E Dupuy,et al.  Image-guided radiofrequency tumor ablation: challenges and opportunities--part II. , 2001, Journal of vascular and interventional radiology : JVIR.

[15]  S. Fan,et al.  Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective , 2002, Annals of surgery.

[16]  Wei Yang,et al.  Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach , 2008, Abdominal Imaging.

[17]  Wei Yang,et al.  Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. , 2008, European journal of radiology.

[18]  G. Dodd,et al.  Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. , 2001, AJR. American journal of roentgenology.

[19]  E. Vicaut,et al.  Radiofrequency ablation of hepatocellular carcinoma: Long‐term results and prognostic factors in 235 Western patients with cirrhosis , 2009, Hepatology.

[20]  D. Gouma,et al.  Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  R. Jenkins,et al.  Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survival , 1996, Cancer.

[22]  M. Makuuchi,et al.  Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. , 2006, World journal of gastroenterology.

[23]  Masatoshi Kudo,et al.  Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Manual Proposed by the Japan Society of Hepatology , 2007, Oncology.

[24]  H. Yoshida,et al.  Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract , 2006, The British journal of surgery.

[25]  Seung‐Mo Hong,et al.  Address reprint requests to: , 2004 .

[26]  T. López-Cuadrado,et al.  Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma , 2009, BMC gastroenterology.

[27]  Luigi Solbiati,et al.  Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? , 2007, Hepatology.

[28]  H. Rhim,et al.  Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients , 2009, European Radiology.

[29]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[30]  B. Choi,et al.  A Comparative Experimental Study of the In-vitro Efficiency of Hypertonic Saline-Enhanced Hepatic Bipolar and Monopolar Radiofrequency Ablation , 2003, Korean journal of radiology.

[31]  T. Kawabe,et al.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. , 2005, Gastroenterology.

[32]  M. Colombo,et al.  Epidemiology of hepatocellular carcinoma. , 1995, The Italian journal of gastroenterology.

[33]  H. Tsubouchi,et al.  Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. , 2009, Journal of hepato-biliary-pancreatic surgery.

[34]  W R Lees,et al.  Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[35]  S. Paik,et al.  Combined Hepatectomy and Radiofrequency Ablation for Multifocal Hepatocellular Carcinomas: Long-term Follow-up Results and Prognostic Factors , 2007, Annals of Surgical Oncology.

[36]  E. Hahn,et al.  Percutaneous Ultrasound-Guided Radiofrequency Ablation (RFA) Using Saline-Perfused (Wet) Needle Electrodes for the Treatment of Hepatocellular Carcinoma - Long Term Experience , 2007, Ultraschall in der Medizin.

[37]  C. Georgiades,et al.  Technology Insight: image-guided therapies for hepatocellular carcinoma—intra-arterial and ablative techniques , 2006, Nature Clinical Practice Oncology.

[38]  Carlo Bartolozzi,et al.  Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. , 2005, Radiology.

[39]  K. Takeda,et al.  Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. , 2003, Journal of vascular and interventional radiology : JVIR.

[40]  Shinpei Sato,et al.  Percutaneous radiofrequency ablation for hepatocellular carcinoma , 2005, Cancer.

[41]  C-J. S. Lin,et al.  Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less , 2005, Gut.

[42]  M. Choi,et al.  Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series , 2007, European Radiology.

[43]  Paolo Bianchi,et al.  Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: A multivariate analysis , 2007, Journal of Gastrointestinal Surgery.

[44]  E. Hatano,et al.  Percutaneous radiofrequency ablation therapy after intrathoracic saline solution infusion for liver tumor in the hepatic dome. , 2002, Journal of vascular and interventional radiology : JVIR.

[45]  S. Mulier,et al.  Complications of radiofrequency coagulation of liver tumours , 2002, The British journal of surgery.

[46]  R. Poon.  Radiofrequency Ablation Combined with Resection Enhances Chance for Curative Treatment of Hepatocellular Carcinoma , 2007, Annals of surgical oncology.

[47]  Y. Hiasa,et al.  Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites , 2007, Journal of Gastroenterology.

[48]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[49]  C. Bartolozzi,et al.  Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma , 2005, Abdominal Imaging.

[50]  T. de Baère,et al.  Adverse events during radiofrequency treatment of 582 hepatic tumors. , 2003, AJR. American journal of roentgenology.

[51]  M. Vivarelli,et al.  Surgical Resection Versus Percutaneous Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma on Cirrhotic Liver , 2004, Annals of surgery.

[52]  Cheol Min Park,et al.  Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[53]  H. Rhim,et al.  Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. , 2008, AJR. American journal of roentgenology.

[54]  M. Makuuchi,et al.  Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. , 2009, Journal of hepatology.

[55]  D E Dupuy,et al.  Image-guided radiofrequency tumor ablation: challenges and opportunities--part I. , 2001, Journal of vascular and interventional radiology : JVIR.

[56]  Joon Koo Han,et al.  Multiple-Electrode Radiofrequency Ablation of In Vivo Porcine Liver: Comparative Studies of Consecutive Monopolar, Switching Monopolar Versus Multipolar Modes , 2007, Investigative radiology.